Neogen Chemicals

Why is Neogen Chemicals Ltd falling/rising?

As of 07-Aug, Neogen Chemicals Ltd's stock price is 2,029.15, down slightly by 0.17%. Despite this minor decline, the stock has shown strong performance trends, including a 71.38% year-to-date increase and solid fundamentals that suggest potential for future growth.

As of 07-Aug, Neogen Chemicals Ltd's stock price is currently at 2,029.15, reflecting a slight decline of 3.4 points or 0.17%. Despite this minor drop, the stock has shown positive performance trends over various periods. For instance, over the past month, the stock has increased by 3.66%, and year-to-date, it has surged by an impressive 71.38%. Additionally, the stock has outperformed the broader market, with a one-year return of 43.65% compared to the market's 4.11%.<BR><BR>Today's trading session began with a notable gain, as the stock opened up by 5.78% and reached an intraday high of Rs 2,150. This indicates strong initial investor interest. However, the stock has experienced high volatility today, with an intraday fluctuation of 5.48%. Furthermore, there has been a significant drop in investor participation, with delivery volume falling by 48.01% compared to the five-day average, which may contribute to the current price decline.<BR><BR>The company's recent positive financial results, including a 122.5% growth in profit before tax and record net sales, suggest strong fundamentals that could support the stock's price in the long term. Additionally, high institutional holdings at 23.71% indicate confidence from more sophisticated investors. Overall, while the stock is currently experiencing a minor decline, its recent performance and strong fundamentals suggest potential for recovery and growth in the future.

Which are the latest news on Neogen Chemicals?

Are Neogen Chemicals Ltd latest results good or bad?

Neogen Chemicals Ltd's latest results show strong growth with a 66.76% increase in net profit and a 34.04% rise in revenue, but concerns about high debt levels and low return on equity have led analysts to issue a HOLD rating. Investors should weigh the impressive growth against the company's financial challenges.

Neogen Chemicals Ltd's latest results present a mixed picture. On the positive side, the company reported a net profit of ₹17.11 crores for Q1 FY27, which is a significant increase of 66.76% year-on-year and a 50.22% rise compared to the previous quarter. Revenue also grew by 34.04% year-on-year, reaching ₹250.29 crores, marking the highest quarterly revenue in recent history. Additionally, the operating margin expanded to 19.27%, the highest in eight quarters.<BR><BR>However, despite these impressive headline figures, there are underlying concerns. The company is facing structural challenges, including elevated debt levels, with a debt-to-equity ratio of 1.71 and a debt-to-EBITDA ratio of 4.82. These metrics indicate significant financial stress and limit the company's operational flexibility. The return on equity (ROE) is relatively low at 6.86%, suggesting poor capital efficiency.<BR><BR>Analysts have issued a HOLD rating, reflecting caution due to these financial pressures despite the growth in revenue and profit. The company's ability to maintain its growth trajectory while managing its debt will be crucial in the coming quarters. Overall, while the quarterly results show strong growth, the financial health and operational efficiency raise red flags that investors should consider.

Should I buy, sell or hold Neogen Chemicals Ltd?

When is the next results date for Neogen Chemicals Ltd?

The next results date for Neogen Chemicals Ltd is 24 July 2026.

The next results date for Neogen Chemicals Ltd is scheduled for 24 July 2026.

What does Neogen Chemicals do?

Neogen Chemicals Ltd is a manufacturer of bromine-based compounds, lithium and bromine salts, and grignard chemicals, operating in the specialty chemicals sector. As of March 2026, it reported net sales of ₹247 Cr and a net profit of ₹11 Cr, with a market cap of ₹5,292 Cr.

Overview:<BR>Neogen Chemicals Ltd is a leading manufacturer of bromine-based compounds, lithium and bromine salts, and grignard chemicals, operating in the specialty chemicals industry within the small-cap market.<BR><BR>History:<BR>Neogen Chemicals Limited was incorporated as a Private Limited Company on March 7, 1989, in Thane, Maharashtra. It was converted to a Public Limited Company and renamed on July 2, 1998. The most recent quarterly results report net sales and net profit for March 2026.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 247 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 11 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 5,292 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 189.00 <BR>Industry P/E: 42 <BR>Dividend Yield: 0.05% <BR>Debt-Equity: 1.70 <BR>Return on Equity: 3.52% <BR>Price to Book: 6.52 <BR><BR>Contact Details:<BR>Details: No Company Details Available <BR>Registrar Address: Not available.

How big is Neogen Chemicals?

As of 10th June, Neogen Chemicals Ltd has a market capitalization of 5,292.00 Cr, with net sales of 861.97 Cr and a net profit of 28.71 Cr reported in the latest four quarters.

As of 10th June, Neogen Chemicals Ltd has a market capitalization of 5,292.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, Neogen Chemicals reported net sales of 861.97 Cr and a net profit of 28.71 Cr.<BR><BR>The latest annual reporting period for the balance sheet is March 2025, with shareholder's funds amounting to 789.39 Cr and total assets of 1,747.31 Cr.

Who are in the management team of Neogen Chemicals?

The management team of Neogen Chemicals includes Chairman Haridas Kanani, Managing Director Harin Kanani, and several independent directors, along with the Company Secretary Unnati Kanani, who collectively guide the company's strategic direction and operations.

The management team of Neogen Chemicals includes the following key individuals:<BR><BR>1. **Haridas Thakarshi Kanani** - Chairman & Executive Director<BR>2. **Harin Haridas Kanani** - Executive Director / Managing Director / Promoter<BR>3. **Anurag Surana** - Non-Executive & Non-Independent Director<BR>4. **Sanjay N Mehta** - Independent Non-Executive Director<BR>5. **Hitesh Bharatkumar Reshamwala** - Independent Non-Executive Director<BR>6. **Shyamsundar Radheshyam Upadhyay** - Executive Director & Wholetime Director<BR>7. **Ranjan Kumar Malik** - Independent Non-Executive Director<BR>8. **Avi Kersi Sabavala** - Independent Non-Executive Director<BR>9. **Unnati Kanani** - Company Secretary & Compliance Officer<BR><BR>This team plays a crucial role in guiding the company's strategic direction and operations.

Who are the peers of the Neogen Chemicals?

Neogen Chemicals' peers include Clean Science, Elantas Beck, Balaji Amines, Archean Chemical, Galaxy Surfact., Epigral, Fineotex Chem, Laxmi Organic, Vishnu Chemicals, and Styrenix Perfor. Most peers have Below Average growth, with Balaji Amines showing the highest 1-year return at 44.21%, while Neogen Chemicals has an 18.07% return.

Peers: The peers of Neogen Chemicals are Clean Science, Elantas Beck, Balaji Amines, Archean Chemical, Galaxy Surfact., Epigral, Fineotex Chem, Laxmi Organic, Vishnu Chemicals, and Styrenix Perfor.<BR><BR>Quality Snapshot: Excellent management risk is observed at Clean Science, while Good management risk is found at Elantas Beck, Archean Chemical, Epigral, Fineotex Chem, and Vishnu Chemicals, and Average management risk is found at Balaji Amines, Galaxy Surfact., Laxmi Organic, and Neogen Chemicals. All peers exhibit Below Average growth except for Fineotex Chem and Vishnu Chemicals, which have Average and Good growth respectively. Capital Structure ratings show Excellent for Clean Science, Elantas Beck, Balaji Amines, Archean Chemical, Galaxy Surfact., Fineotex Chem, and Laxmi Organic, while Neogen Chemicals has Below Average, and the rest have Good or Average ratings.<BR><BR>Return Snapshot: Balaji Amines has the highest 1-year return at 44.21%, while Epigral has the lowest at -40.00%. Neogen Chemicals' 1-year return of 18.07% is higher than that of Epigral but lower than Balaji Amines. Additionally, the six-month returns are negative for Epigral, Galaxy Surfact., and Laxmi Organic.

Is Neogen Chemicals overvalued or undervalued?

As of November 24, 2025, Neogen Chemicals is considered overvalued with a valuation grade of expensive, highlighted by a PE ratio of 86.07, significantly higher than peers like Godrej Industries and Deepak Nitrite, and a poor year-to-date return of -47.89% compared to the Sensex's 8.65% gain.

As of 24 November 2025, the valuation grade for Neogen Chemicals has moved from very expensive to expensive. The company is currently considered overvalued. Key ratios include a PE ratio of 86.07, an EV to EBITDA of 30.31, and a Price to Book Value of 3.80. <BR><BR>When compared to peers, Neogen's PE ratio significantly exceeds that of Godrej Industries, which stands at 35.62, and Deepak Nitrite at 41.71, both of which are categorized as expensive. The recent stock performance has been notably poor, with a year-to-date return of -47.89%, contrasting sharply with the Sensex's gain of 8.65% during the same period, reinforcing the overvaluation narrative.

Is Neogen Chemicals technically bullish or bearish?

As of November 10, 2025, Neogen Chemicals is in a bearish trend with strong weakness indicated by bearish MACD and Bollinger Bands signals, despite a mildly bullish KST signal.

As of 10 November 2025, the technical trend for Neogen Chemicals has changed from mildly bearish to bearish. The current stance is bearish with a strong indication of weakness. Key indicators driving this assessment include bearish signals from both the MACD and Bollinger Bands on weekly and monthly time frames, alongside a bearish moving average on the daily chart. The Dow Theory also reflects a mildly bearish outlook on both weekly and monthly levels. Despite the KST showing a mildly bullish signal weekly, the overall technical picture remains negative, particularly given the significant decline in stock performance relative to the Sensex over multiple time frames.

How has been the historical performance of Neogen Chemicals?

Neogen Chemicals has shown consistent growth in net sales, increasing from 306.12 Cr in Mar'20 to 777.56 Cr in Mar'25, despite fluctuations in profit margins and rising raw material costs. Total assets grew significantly, while cash flow from operating activities improved to 195.00 Cr in Mar'25, indicating resilience in its financial performance.

Answer:<BR>The historical performance of Neogen Chemicals shows a consistent growth trend in net sales and profits over the years, with some fluctuations in profit margins.<BR><BR>Breakdown:<BR>Neogen Chemicals has demonstrated significant growth in net sales, increasing from 306.12 Cr in Mar'20 to 777.56 Cr in Mar'25. The total operating income followed a similar trajectory, rising from 306.12 Cr in Mar'20 to 777.56 Cr in Mar'25. However, the raw material costs also increased, reaching 506.08 Cr in Mar'25, which impacted the operating profit, which was 136.32 Cr in Mar'25 compared to 110.05 Cr in Mar'24. The profit before tax showed some volatility, peaking at 70.93 Cr in Mar'23 but dropping to 49.96 Cr in Mar'25. Profit after tax also experienced fluctuations, with a high of 49.87 Cr in Mar'23 and a decrease to 34.63 Cr in Mar'25. The company's total assets grew from 354.85 Cr in Mar'20 to 1,747.31 Cr in Mar'25, while total liabilities increased from 354.85 Cr to 566.04 Cr in the same period. The cash flow from operating activities improved significantly to 195.00 Cr in Mar'25, contrasting with negative cash flow in previous years. Overall, Neogen Chemicals has shown resilience and growth in its financial metrics, despite some challenges in profit margins and costs.

Who are the top shareholders of the Neogen Chemicals?

The top shareholders of Neogen Chemicals include Haridas Thakarshi Kanani, who holds 39.44%, mutual funds with 20.24%, foreign institutional investors at 7.79%, and individual investors owning 12.89%. The SBI Large & Midcap Fund is the largest public shareholder with 7.69%.

The top shareholders of Neogen Chemicals include the promoters, who hold a significant majority of the shares. The promoter with the highest holding is Haridas Thakarshi Kanani, owning 39.44% of the company. Additionally, mutual funds collectively hold 20.24% through 15 different schemes, while foreign institutional investors (FIIs) account for 7.79% with 64 FIIs involved. The highest public shareholder is the SBI Large & Midcap Fund, which holds 7.69%. Individual investors also have a notable presence, holding 12.89% of the shares.

Has Neogen Chemicals declared dividend?

Neogen Chemicals Ltd has declared a 20% dividend, amounting to ₹2 per share, with an ex-date of September 19, 2024. The dividend yield is 0.12%, and while recent total returns have fluctuated, the company has shown significant growth over the past five years.

Neogen Chemicals Ltd has declared a 20% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 20%<BR>- Amount per share: 2 per share<BR>- Ex-date: 19 Sep 24<BR><BR>Dividend Yield: 0.12%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -23.16%, with a dividend return of 0%, resulting in a total return of -23.16%.<BR><BR>Over the past year, the price return was 10.39%, the dividend return was 0.13%, leading to a total return of 10.52%.<BR><BR>In the 2-year period, the price return was 4.32%, with a dividend return of 0.31%, culminating in a total return of 4.63%.<BR><BR>For the 3-year period, the price return was 13.7%, the dividend return was 0.59%, which resulted in a total return of 14.29%.<BR><BR>In the last 4 years, the price return was 85.69%, with a dividend return of 1.18%, giving a total return of 86.87%.<BR><BR>Over the past 5 years, the price return was 259.73%, the dividend return was 2.25%, leading to a total return of 261.98%.<BR><BR>Overall, Neogen Chemicals has declared a dividend, and while the recent total returns have varied, the long-term performance shows significant growth, particularly over the 5-year period. The dividend yield remains modest, reflecting a balance between price appreciation and dividend distribution.